Submit Today with Zero Submission Fees
Antioxidants & Redox Signaling welcomes current and original reviews, research reports, and short communications for upcoming publication. The Journal is seeking high-quality, innovative submissions to be published in our 2023 and 2024 volume years.
The Journal is an authoritative, peer-reviewed journal dedicated to understanding of the vital impact of oxygen and oxidation-reduction (redox) processes on human health and disease, exploring key issues in genetic, pharmaceutical, and nutritional redox-based therapeutics. The Journal explores key issues in genetic, pharmaceutical, and nutritional redox-based therapeutics. Antioxidants & Redox Signaling is under the editorial leadership of Editor-in-Chief Editor-in-Chief Chandan K. Sen, PhD, Indiana University School of Medicine, and other leading investigators. View the entire editorial board.
The Journal is currently seeking submissions on the following topics:
- ROS/RNS as messengers
- Gaseous signal transducers
- Hypoxia and tissue oxygenation
- microRNA
- Prokaryotic systems
- Lessons from plant biology
Benefits of publishing with Antioxidants & Redox Signaling:
- No submission fees
- Latest Impact Factor: 7.468
- Average time to first decision: 13 days
- Expert peer review and editorial oversight of your manuscript from leading specialists in your field
- Zero-embargo Green Open Access
- Immediate deposit of your work to PubMed and other indexing services upon publication
- Free 30-day access to share your published research with your networks and colleagues
- Global visibility in more than 170 countries worldwide
We are eager to consider your research and look forward to your submission! Visit the Journal's website to view more information for authors including manuscript guidelines, information on available author services, and publication costs.